229 related articles for article (PubMed ID: 7522742)
1. Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosis.
Yang Y; Nunes FA; Berencsi K; Gönczöl E; Engelhardt JF; Wilson JM
Nat Genet; 1994 Jul; 7(3):362-9. PubMed ID: 7522742
[TBL] [Abstract][Full Text] [Related]
2. Prolonged transgene expression in cotton rat lung with recombinant adenoviruses defective in E2a.
Engelhardt JF; Litzky L; Wilson JM
Hum Gene Ther; 1994 Oct; 5(10):1217-29. PubMed ID: 7849095
[TBL] [Abstract][Full Text] [Related]
3. Persistence of replication-deficient adenovirus-mediated gene transfer in lungs of immune-deficient (nu/nu) mice.
Zsengeller ZK; Wert SE; Hull WM; Hu X; Yei S; Trapnell BC; Whitsett JA
Hum Gene Ther; 1995 Apr; 6(4):457-67. PubMed ID: 7612702
[TBL] [Abstract][Full Text] [Related]
4. Transfer of the CFTR gene to the lung of nonhuman primates with E1-deleted, E2a-defective recombinant adenoviruses: a preclinical toxicology study.
Goldman MJ; Litzky LA; Engelhardt JF; Wilson JM
Hum Gene Ther; 1995 Jul; 6(7):839-51. PubMed ID: 7578403
[TBL] [Abstract][Full Text] [Related]
5. Direct gene transfer of human CFTR into human bronchial epithelia of xenografts with E1-deleted adenoviruses.
Engelhardt JF; Yang Y; Stratford-Perricaudet LD; Allen ED; Kozarsky K; Perricaudet M; Yankaskas JR; Wilson JM
Nat Genet; 1993 May; 4(1):27-34. PubMed ID: 7685651
[TBL] [Abstract][Full Text] [Related]
6. Systematic analysis of repeated gene delivery into animal lungs with a recombinant adenovirus vector.
Dong JY; Wang D; Van Ginkel FW; Pascual DW; Frizzell RA
Hum Gene Ther; 1996 Feb; 7(3):319-31. PubMed ID: 8835219
[TBL] [Abstract][Full Text] [Related]
7. Recombinant adenovirus deleted of all viral genes for gene therapy of cystic fibrosis.
Fisher KJ; Choi H; Burda J; Chen SJ; Wilson JM
Virology; 1996 Mar; 217(1):11-22. PubMed ID: 8599194
[TBL] [Abstract][Full Text] [Related]
8. Gene therapy of cystic fibrosis lung disease using E1 deleted adenoviruses: a phase I trial.
Wilson JM; Engelhardt JF; Grossman M; Simon RH; Yang Y
Hum Gene Ther; 1994 Apr; 5(4):501-19. PubMed ID: 7519452
[No Abstract] [Full Text] [Related]
9. Gene therapy for cystic fibrosis using E1-deleted adenovirus: a phase I trial in the nasal cavity. The University of North Carolina at Chapel Hill.
Boucher RC; Knowles MR; Johnson LG; Olsen JC; Pickles R; Wilson JM; Engelhardt J; Yang Y; Grossman M
Hum Gene Ther; 1994 May; 5(5):615-39. PubMed ID: 7519885
[TBL] [Abstract][Full Text] [Related]
10. Safety of adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator cDNA to the lungs of nonhuman primates.
Wilmott RW; Amin RS; Perez CR; Wert SE; Keller G; Boivin GP; Hirsch R; De Inocencio J; Lu P; Reising SF; Yei S; Whitsett JA; Trapnell BC
Hum Gene Ther; 1996 Feb; 7(3):301-18. PubMed ID: 8835218
[TBL] [Abstract][Full Text] [Related]
11. Acute responses of non-human primates to airway delivery of an adenovirus vector containing the human cystic fibrosis transmembrane conductance regulator cDNA.
Brody SL; Metzger M; Danel C; Rosenfeld MA; Crystal RG
Hum Gene Ther; 1994 Jul; 5(7):821-36. PubMed ID: 7526901
[TBL] [Abstract][Full Text] [Related]
12. Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver.
Engelhardt JF; Ye X; Doranz B; Wilson JM
Proc Natl Acad Sci U S A; 1994 Jun; 91(13):6196-200. PubMed ID: 8016137
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the respiratory epithelium of normals and individuals with cystic fibrosis for the presence of adenovirus E1a sequences relevant to the use of E1a- adenovirus vectors for gene therapy for the respiratory manifestations of cystic fibrosis.
Eissa NT; Chu CS; Danel C; Crystal RG
Hum Gene Ther; 1994 Sep; 5(9):1105-14. PubMed ID: 7833370
[TBL] [Abstract][Full Text] [Related]
14. Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy.
Yang Y; Nunes FA; Berencsi K; Furth EE; Gönczöl E; Wilson JM
Proc Natl Acad Sci U S A; 1994 May; 91(10):4407-11. PubMed ID: 8183921
[TBL] [Abstract][Full Text] [Related]
15. Direct in vivo gene transfer and expression in malignant cells using adenovirus vectors.
Brody SL; Jaffe HA; Han SK; Wersto RP; Crystal RG
Hum Gene Ther; 1994 Apr; 5(4):437-47. PubMed ID: 7519451
[TBL] [Abstract][Full Text] [Related]
16. Development and analysis of recombinant adenoviruses for gene therapy of cystic fibrosis.
Rich DP; Couture LA; Cardoza LM; Guiggio VM; Armentano D; Espino PC; Hehir K; Welsh MJ; Smith AE; Gregory RJ
Hum Gene Ther; 1993 Aug; 4(4):461-76. PubMed ID: 7691187
[TBL] [Abstract][Full Text] [Related]
17. Trans-complementation of E1-deleted adenovirus: a new vector to reduce the possibility of codissemination of wild-type and recombinant adenoviruses.
Imler JL; Bout A; Dreyer D; Dieterlé A; Schultz H; Valerio D; Mehtali M; Pavirani A
Hum Gene Ther; 1995 Jun; 6(6):711-21. PubMed ID: 7548271
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo biology of recombinant adenovirus vectors with E1, E1/E2A, or E1/E4 deleted.
Lusky M; Christ M; Rittner K; Dieterle A; Dreyer D; Mourot B; Schultz H; Stoeckel F; Pavirani A; Mehtali M
J Virol; 1998 Mar; 72(3):2022-32. PubMed ID: 9499056
[TBL] [Abstract][Full Text] [Related]
19. Selective gene transfer into the liver of non-human primates with E1-deleted, E2A-defective, or E1-E4 deleted recombinant adenoviruses.
Raper SE; Haskal ZJ; Ye X; Pugh C; Furth EE; Gao GP; Wilson JM
Hum Gene Ther; 1998 Mar; 9(5):671-9. PubMed ID: 9551615
[TBL] [Abstract][Full Text] [Related]
20. Adenovirus-mediated gene transfer for cystic fibrosis: quantitative evaluation of repeated in vivo vector administration to the lung.
Yei S; Mittereder N; Tang K; O'Sullivan C; Trapnell BC
Gene Ther; 1994 May; 1(3):192-200. PubMed ID: 7584081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
